Qualitative and Quantitative Heterogeniety in Acquiring Resistance to EGFR Kinase Inhibitors in Lung Cancer

被引:0
作者
Suda, Kenichi [1 ]
Murakami, Isao [2 ]
Sakai, Kazuko [3 ]
Mizuuchi, Hiroshi [1 ]
Sato, Katsuaki [1 ]
Tomizawa, Kenji [1 ]
Nishio, Kazuto [3 ]
Mitsudomi, Tetsuya [1 ]
机构
[1] Kinki Univ, Fac Med, Dept Surg, Div Thorac Surg, Osaka, Japan
[2] Higashi Hiroshima Med Ctr, Dept Resp Med, Higashihiroshima, Japan
[3] Kinki Univ, Fac Med, Dept Genome Biol, Osaka, Japan
关键词
T790M mutation; Molecular targeted therapy; EGFR mutation; lung adenocarcinoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ORAL42.02
引用
收藏
页码:S256 / S257
页数:2
相关论文
共 50 条
[21]   Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation [J].
Bruno, Rossella ;
Del Re, Marzia ;
Cucchiara, Federico ;
Petrini, Iacopo ;
Ali, Greta ;
Crucitta, Stefania ;
Proietti, Agnese ;
Valleggi, Simona ;
Chella, Antonio ;
Danesi, Romano ;
Fontanini, Gabriella .
FRONTIERS IN ONCOLOGY, 2021, 11
[22]   Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategy [J].
Samer Tabchi ;
Hampig Raphael Kourie ;
Joseph Kattan .
Investigational New Drugs, 2016, 34 :794-796
[23]   Adding checkpoint inhibitors to tyrosine kinase inhibitors targeting EGFR/ALK in non-small cell lung cancer: a new therapeutic strategy [J].
Tabchi, Samer ;
Kourie, Hampig Raphael ;
Kattan, Joseph .
INVESTIGATIONAL NEW DRUGS, 2016, 34 (06) :794-796
[24]   Osteoblastic Response in Patients with Non-small Cell Lung Cancer with Activating EGFR Mutations and Bone Metastases during Treatment with EGFR Kinase Inhibitors [J].
Ansen, Sascha ;
Bangard, Christopher ;
Querings, Silvia ;
Gabler, Franziska ;
Scheffler, Matthias ;
Seidel, Daniela ;
Saal, Beate ;
Zander, Thomas ;
Nogova, Lucia ;
Toepelt, Karin ;
Markert, Eva ;
Stoelben, Erich ;
Ernestus, Karen ;
Thomas, Roman K. ;
Wolf, Juergen .
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (03) :407-409
[25]   Insensitivity of oncogenic EGFR R776L mutation to EGFR inhibitors in lung cancer [J].
Wang, Yun ;
Hu, Chen ;
Yu, Hongwei ;
Hu, Jie ;
Zhou, Zhiwei ;
Fu, Ning ;
Huang, Xiang ;
Kong, Fanhao ;
Wang, Wenchao ;
Liu, Jing .
LUNG CANCER, 2024, 189
[26]   Early On-Treatment Prediction of the Mechanisms of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors [J].
Choi, Yu-Ra ;
Cho, Youngnam ;
Park, Seog-Yun ;
Kim, Sunshin ;
Shin, Myungsun ;
Choi, Yongdoo ;
Shin, Dong Hoon ;
Han, Ji-Youn ;
Lee, Youngjoo .
CANCERS, 2022, 14 (06)
[27]   A Progression Free Survival Score for EGFR Mutant Non-Small Cell Lung Cancer Patients Treat with First Line EGFR Tyrosine Kinase Inhibitors [J].
Chen, Yu-Mu ;
Lin, Meng-Chih ;
Fang, Wen-Feng ;
Lie, Chien-Hao ;
Chang, Huang-Chih .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) :S276-S277
[28]   Induction EGFR tyrosine kinase inhibitors prior to definitive chemoradiotherapy in unresectable stage III EGFR-mutated non-small cell lung cancer [J].
Aredo, Jacqueline V. ;
Wakelee, Heather A. ;
Hui, Angela Bik-Yu ;
Padda, Sukhmani K. ;
Joshi, Nitin D. ;
Guo, H. Henry ;
Chaudhuri, Aadel ;
Diehn, Maximilian ;
Loo, Billy W. ;
Neal, Joel W. .
CANCER TREATMENT AND RESEARCH COMMUNICATIONS, 2022, 33
[29]   EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors [J].
Yang, Jiyoul ;
Lee, Ok-Jun ;
Son, Seung-Myoung ;
Woo, Chang Gok ;
Jeong, Yusook ;
Yang, Yaewon ;
Kwon, Jihyun ;
Lee, Ki Hyeong ;
Han, Hye Sook .
CANCER RESEARCH AND TREATMENT, 2018, 50 (03) :908-916
[30]   In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer [J].
Hirano, Toshiyuki ;
Yasuda, Hiroyuki ;
Tani, Tetsuo ;
Hamamoto, Junko ;
Oashi, Ayano ;
Ishioka, Kota ;
Arai, Daisuke ;
Nukaga, Shigenari ;
Miyawaki, Masayoshi ;
Kawada, Ichiro ;
Naoki, Katsuhiko ;
Costa, Daniel B. ;
Kobayashi, Susumu S. ;
Betsuyaku, Tomoko ;
Soejima, Kenzo .
ONCOTARGET, 2015, 6 (36) :38789-38803